Anti-inflammatory biologics represent a significant advancement in the treatment of chronic inflammatory diseases, offering precision and effectiveness that distinguishes them from traditional pharmaceuticals. These biologics are derived from living organisms or developed through sophisticated biotechnological methods. Their primary advantage lies in their ability to specifically target and modulate components of the immune system's inflammatory response, aiming to address the underlying causes of diseases rather than simply providing symptomatic relief.